Peptide record

TPDB91294

Citropin 1.1 Citropin1.1 Anti-inflammatory Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Neuropeptide Toxicity modified_plain modified
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91294
Citropin 1.1 Citropin1.1
Anti-inflammatory Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Neuropeptide Toxicity
Anti-infective peptides Cancer-related peptides Immunity and inflammation peptides Toxicity and safety peptides Neuroactive peptides
Peptipedia AntiBP3 dbAMP DRAMP ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF AFP-GFuse Antifungipept CAFPdb APD_complete PD_Hemolysis ToxinPred 3.0
modified_plain
Yes
A 16-aa modified multi-activity (Anti-inflammatory, Antibacterial, Anticancer, and other sources) peptide sequence curated from Peptipedia, AntiBP3, dbAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
GLFDVIKKVASVIGGL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
16 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antibacterial Antimicrobial and Anticancer Antimicrobial Activity
Australian blue mountains tree frog, Litoria citropa Amphibian skin secretions Activity
Evidence Records 11 records
Evidence 1 Activity

Activity

60% Cytotoxicity at 0.5 µg/ml
Anticancer

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

MTT/MTS assay
6-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2009

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Leukemia Cancer
Leukemia tumor cellline
Blood

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 3 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Lung Cancer
Lung tumor cellline
Lung

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 4 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Colon Cancer
Colon tumor cellline
Colon

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 5 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Brain Tumor
Brain tumor cellline
Brain

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 6 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Skin Cancer
Skin tumor cellline
Skin

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 7 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Ovarian Cancer
Ovary tumor cellline
Ovary

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 8 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Liver Cancer
Liver tumor celline
Liver

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 9 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Prostate Cancer
Prostate tumor cellline
Prostate

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 10 Activity

Activity

IC50
IC50= 5 M
Anticancer
5

Target

Breast Cancer
Breast tumor cellline
Breast

Assay & Model

Sulforhodamine B assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003
Evidence 11 Activity

Activity

IC50
IC50 =40 µg/ml
Anticancer
40 µg/mL

Target

Lymphoma Cancer
U-938
Blood

Assay & Model

MTT/MTS assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2011